We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
51 hedge funds and large institutions have $17M invested in Larimar Therapeutics in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.78% less ownership
Funds ownership: 5.9% → 5.12% (-0.78%)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
28% less funds holding
Funds holding: 71 → 51 (-20)
46% less capital invested
Capital invested by funds: $31.5M → $17M (-$14.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 27
Holders
51
Holders Change
-20
Holders Change %
-28.17%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
15
Reduced
16
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.78M |
| 2 |
Morgan Stanley
New York
|
+$1.41M |
| 3 |
6CM
683 Capital Management
New York
|
+$910K |
| 4 |
Renaissance Technologies
New York
|
+$468K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$191K |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.63M |
| 2 |
AC
Armistice Capital
New York
|
-$2.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.16M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$522K |
